Sign up USA
Proactive Investors - Run By Investors For Investors

Pressure BioSciences has an eye toward uplisting as it strengthens balance sheet

Pressure BioSciences (OTCMKTS:PBIO, OTCQB: PBIO) CEO Ric Schumacher tells Proactive Investors the life sciences company has strengthened its balance sheet with the conversion of an additional $7.24mln of debt into equity, bringing the total amount of debt that has converted into equity over the past four weeks to more than $13.6mln.

Schumacher says the company is on track to uplist to a national exchange, and would like to make the move by the end of the year.

 
Meet Permex Petroleum Corporation and Landos Biopharma at our event, New York , 18 July 2018. Register here »
View full PBIO profile View Profile

Pressure BioSciences Inc Timeline

Copyright © Proactiveinvestors.com, 2018. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use